Country mission Estonia: HIV, sexually transmitted infections, and hepatitis B and C
Following a request by the Estonian government, ECDC performed a follow-up country visit to Estonia covering HIV and sexually transmitted infections (STIs) from 11–13 October 2010, following an earlier visit in 2007. The team consisted of ECDC representatives and delegates from the Estonian National Institute for Health Development.The key areas identified following the visit were: expansion of point-of-care testing in community-based settings; strengthening the integration of HIV and STI care; effective partner notification; improving the quality and harmonisation of HIV and STI surveillance data; and efficient regional networking.
HIV Pre-Exposure Prophylaxis in the EU/EEA and the UK: implementation, standards and monitoring
5 Mar 2021 - This operational guidance document provides practical recommendations and key considerations to inform the development and implementation of PrEP programmes at national and sub-national levels throughout the EU/EEA.
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
30 Mar 2020 - This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Toolkit to support the generation of robust estimates of hepatitis C prevalence
5 Mar 2020 - European surveillance data show on-going transmission of viral hepatitis across the European Union and European Economic Area (EU/EEA). The available notification data however, do not provide a clear epidemiological picture of hepatitis C in Europe. Prevalence data from population surveys are a key source of information to complement the surveillance data for hepatitis C due to the limitations of surveillance for hepatitis: the infection is often asymptomatic and notifications are strongly influenced by local testing practices. The overarching aim of this toolkit is to gain a better understanding of the HCV epidemiology in the EU/EEA.